Skip to main content

Reliable urinary test for the diagnosis of prostate cancer

Project description

Simple urine test to detect prostate cancer early

In Europe, prostate cancer is the most frequently diagnosed cancer among men. Despite the significant public health burden, late detection of advanced prostate cancer remains a major issue. The need for population-based prostate cancer screening programmes is growing. The EU-funded PROSTATOR project is developing a reliable urine test for the early diagnosis of prostate cancer that does not require unnecessary biopsies. The test will indicate which patients will need to undergo a biopsy to determine the type and the grade of the prostate tumour. The project will validate its first results on a large sample of 900 urine tests. In addition to the biomarkers quantified by commercialised urine tests, the project has identified three new biomarkers in all grades of tumours.

Call for proposal

ERC-2019-PoC
See other projects for this call

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Host institution

INSTITUT CURIE
Address
Rue D'ulm 26
75231 Paris
France
Activity type
Research Organisations
EU contribution
€ 150 000

Beneficiaries (1)

INSTITUT CURIE
France
EU contribution
€ 150 000
Address
Rue D'ulm 26
75231 Paris
Activity type
Research Organisations